Stock DNA
Pharmaceuticals & Biotechnology
CNY 59,132 Million (Large Cap)
NA (Loss Making)
NA
0.00%
-0.29
-3.16%
4.89
Revenue and Profits:
Net Sales:
655 Million
(Quarterly Results - Sep 2025)
Net Profit:
-28 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-23.95%
0%
-23.95%
6 Months
-27.07%
0%
-27.07%
1 Year
-38.45%
0%
-38.45%
2 Years
-25.09%
0%
-25.09%
3 Years
-54.45%
0%
-54.45%
4 Years
-62.05%
0%
-62.05%
5 Years
-61.62%
0%
-61.62%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
2.62%
EBIT Growth (5y)
-211.49%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.29
Sales to Capital Employed (avg)
0.29
Tax Ratio
35.52%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
37.98%
ROE (avg)
24.39%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
5.86
EV to EBIT
-112.89
EV to EBITDA
-284.30
EV to Capital Employed
8.95
EV to Sales
39.01
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-7.93%
ROE (Latest)
-2.85%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ
Sep'25
Jun'25
Change(%)
Net Sales
654.80
442.90
47.84%
Operating Profit (PBDIT) excl Other Income
-90.80
-58.50
-55.21%
Interest
0.00
11.60
-100.00%
Exceptional Items
5.50
8.80
-37.50%
Consolidate Net Profit
-28.40
-91.40
68.93%
Operating Profit Margin (Excl OI)
-138.70%
-332.20%
19.35%
USD in Million.
Net Sales
QoQ Growth in quarter ended Sep 2025 is 47.84% vs 11.17% in Jun 2025
Consolidated Net Profit
QoQ Growth in quarter ended Sep 2025 is 68.93% vs -68.95% in Jun 2025
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
2,235.60
5,488.50
-59.27%
Operating Profit (PBDIT) excl Other Income
-9.50
1,617.00
-100.59%
Interest
8.80
8.00
10.00%
Exceptional Items
31.20
-234.50
113.30%
Consolidate Net Profit
109.10
1,246.50
-91.25%
Operating Profit Margin (Excl OI)
-146.60%
248.00%
-39.46%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is -59.27% vs -50.70% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is -91.25% vs -74.37% in Dec 2023
About Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. 
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






